Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines

Human Gene Therapy

Volumn 10, Issue 2, 1999, Pages 189-200

  Duisit, Ghislaine ^a   Salvetti, Anna ^a   Moullier, Philippe ^a   Cosset, François Loïc ^b  

^a HÔTEL DIEU   (France)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; GAG PROTEIN; POL PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE TRANSFER; GIBBON LEUKEMIA VIRUS; HUMAN; HUMAN CELL; LIVER CELL CULTURE; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; PRIMATE; RETROVIRUS; VIRUS REPLICATION; VIRUS TITRATION;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD2; CELL LINE; CHIMERA; GENETIC VECTORS; HUMANS; RECOMBINATION, GENETIC; RETROVIRIDAE; VIRAL PROTEINS; VIRUS ASSEMBLY;

EID: 0033585477     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018986     Document Type: Article

References (35)

1. BURNS, J.C., FRIEDMANN, T., DRIEVER, W., BURRASCANO, M., and YEE, J.-K. (1993). Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. U.S.A. 90, 8033-8037.
2. CABRITA, G., IQBAL, M., REDDY, H., and KEMP, G. (1997). Activation of the adenovirus protease requires sequence elements from both ends of the activating peptide. J. Biol. Chem. 272, 5635-5639.
3. COFFIN, J.M. (1996). Retroviridae: The viruses and their replication. In Virology, 3rd Ed. D.M. KLEIN, B.N. FIELDS, and P.M. Howley, eds. (Lippincott-Raven, Philadelphia, PA) pp. 1767-1847.
4. COSSET, F.L., TAKEUCHI, Y., BATTINI, J.L., WEISS, R.A., and COLLINS, M.K.L. (1995). High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69, 7430-7436.
5. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
6. DEFER, C., BELIN, M., CAILLET-BOUDIN, M., and BOULANGER, P. (1990). Human adenovirus-host cell interactions: Comparative study with members of subgroups B and C. J. Virol. 64, 2661-2673.
7. DELASSUS, S., SONIGO, P., and WAIN-HOBSON, S. (1989). Genetic organization of gibbon ape leukemia virus. Virology 173, 205-213.
8. DRANOFF, G., JAFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D., and MULLIGAN, R.C. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long lasting anti-tumor immunity. Proc. Natl. Acad. Sci. U.S.A. 90, 3539-3543.
9. ENGELHARDT, J.F., YANG, Y., STRATFORD-PERRICAUDET, L.D., ALLEN, E.D., KOZARSKY, K., PERRICAUDET, M., YANKASKAS, J.R., and WILSON, J.M. (1993). Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. Nature Genet. 4, 27-34.
10. ENGELHARDT, J.F., YE, X., DORANZ, B., and WILSON, J.M. (1994). Ablation of E2a in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. U.S.A. 91, 6196-6200.
11. FENG, M., JACKSON, W.H., GOLDMAN, C.K., RANCOURT, C., WANG, M., DUSING, S.K., SIEGAL, G., and CURIEL, D.T. (1997). Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector. Nature Biotechnol. 15, 866-870.
12. FINER, M.H., DULL, T.J., QIN, L., FARSON, D., and ROBERTS, M.R. (1994). Kat: A high efficiency retroviral transduction system for primary human lymphocytes. Blood 83, 43-50.
13. GIROD, A., COSSET, F.L., VERDIER, G., and RONFORT, C. (1995). Analysis of ALV-based packaging cell lines for production of contaminant defective viruses. Virology 209, 671-675.
14. GRAHAM, F.L., and PREVEC, L. (1991). Manipulation of adenovirus vectors. In Gene Transfer and Protocol. E.J. Murray, ed. (Humana Press, Clifton, NJ) pp. 109-128.
15. HANAOKA, K., HAYASAKA, M., UETSUKI, T., FUJISAWA-SEHARA, A., and NABESHIMA, Y. (1991). A stable cellular marker for the analysis of mouse chimeras: The bacterial chloramphenicol acetyltransferase gene driven by the human elongation factor 1alpha promoter. Differentiation 48, 183-189.
16. HORWITZ, M.S. (1990). Adenoviridae and their replication. In Virology. B.N. Fields, ed. (Raven Press, New York) pp. 1679-1712.
17. KAPLAN, A.H., MANCHESTER, M., SMITH, T., YANG, Y.L., and SWANSTROM, R. (1996). Conditional human immunodeficiency virus type 1 protease mutants show no role for the viral protease early in virus replication. J. Virol. 70, 5840-5844.
18. KATOH, I., YOSHINAKA, Y., REIN, A., SHIBUYA, M., ODAKA, T., and OROSZLAN, S. (1985). Murine leukemia virus maturation: Protease region required for conversion from "immature" to "mature" core form and for virus infectivity. Virology 145, 280-292.
19. KOZARSKY, K.F., JOOSS, K., DONAHEE, M., STRAUSS, J.F., and WILSON, J.M. (1996). Effective treatment of familial hypercholesterolemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene. Nature Genet. 13, 54-62.
20. LANDAU, N.R., and LITTMAN, D.R. (1992). Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J. Virol. 66, 5110-5113.
21. LI, K.J., and GAROFF, H. (1998). Packaging of intron-containing genes into retrovirus vectors by alphavirus vectors. Proc. Natl. Acad. Sci. U.S.A. 95, 3650-3654.
22. PEAR, W.S., NOLAN, G.P., SCOTT, M.L., and BALTIMORE, D. (1993). Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. U.S.A. 90, 8392-8396.
23. PEARL, L.H., and TAYLOR, W.R. (1987). A structural model for the retroviral proteases. Nature (London) 329, 351-354.
24. REICH, N.C., SARNOW, P., DUPREY, E., and LEVINE, A.J. (1983). Monoclonal antibodies which recognize native and denatured forms of the adenovirus DNA-binding protein. Virology 128, 480-484.
25. SAVARD, N., COSSET, F.L., and EPSTEIN, A.L. (1997). Defective herpes simplex virus type 1 vectors harboring gag, pol, and env genes can be used to rescue defective retrovirus vectors. J. Virol. 71, 4111-4117.
26. SHENK, T. (1996). Adenoviridae: The viruses and their replication. In Virology, 3rd Ed. D.M. Klein, B.N. Fields, and P.M. Howley, eds. (Lippincott-Raven, Philadelphia, PA) pp. 2111-2148.
27. SHINNICK, T.M., LERNER, R.A., and SUTCLIFFE, J.G. (1981). Nucleotide sequence of Moloney murine leukemia virus. Nature (London) 293, 543-548.
28. SMITH, K.T., SHEPERD, A.J., BOYD, J.E., and LEES, G.M. (1996). Gene delivery systems for use in gene therapy: An overview of quality assurance and safety issues. Gene Ther. 3, 190-200.
29. SONEOKA, Y., CANNON, P.M., RAMSDALE, E.E., GRIFFITHS, J.C., ROMANO, G., KINGSMAN, S.M., and KINGSMAN, A.J. (1995). A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23, 628-633.
30. SPERGEL, J.M., HSU, W., AKIRA, S., THIMMAPPAYA, B., KISHIMOTO, T., and CHEN-KIANG, S. (1992). NF-IL6, a member of the C/EBP family, regulates E1a-responsive promoters in the absence of E1a. J. Virol. 66, 1021-1030.
31. TERAMOTO, S., JOHNSON, L.G., HUANG, W., LEIGH, M.W., and BOUCHER, R.C. (1995). Effect of adenoviral vector infection on cell proliferation in cultured primary human airway epithelial cells. Hum. Gene Ther. 6, 1045-1053.
32. VALENTINE, R.C., and PEREIRA, H.G. (1965). Antigens and structure of the adenovirus. J. Mol. Biol. 13, 13-23.
33. WAHLFORD, J.J., XANTHOPOULOS, K.G., and MORGAN, R.A. (1997). Semliki Forest virus-mediated production of retroviral vector RNA in retroviral packaging cells. Hum. Gene Ther. 8, 2031-2041.
34. WEBSTER, A., RUSSELL, S., TALBOT, P., RUSSELL, W.C., and KEMP, G.D. (1989). Characterization of the adenovirus proteinase: substrate specificity. J. Gen. Virol. 70, 3225-3234.
35. YOSHIDA, Y., NOBUHIKO, E., and HAMADA, H. (1997). VSV-G pseudotyped retroviral packaging through adenovirus-mediated inducible gene expression. Biochem. Biophys. Res. Commun. 232, 379-382.